On August 7, 2024 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported the following September 2024 investor events (Press release, Regeneron, AUG 7, 2024, View Source [SID1234645501]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Investor Conference Presentations
• Morgan Stanley 22nd Annual Global Healthcare Conference at 11:30 a.m. ET on
Wednesday, September 4, 2024
• 2024 Wells Fargo Healthcare Conference at 12:45 p.m. ET on Thursday,
September 5, 2024
The sessions may be accessed from the "Investors & Media" page of Regeneron’s website at View Source Replays and transcripts of the webcasts will be archived on the Company’s website for at least 30 days.
Oncology Webcast Information
• European Society for Medical Oncology (ESMO) (Free ESMO Whitepaper) 2024 conference call and webcast at 14:30 CEST/8:30 AM EDT on Monday, September 16, 2024
Regeneron will host a conference call and simultaneous webcast to share updates on the company’s oncology portfolio. A link to the webcast may be accessed from the ‘Investors and Media’ page of Regeneron’s website at View Source To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the conference call and webcast will be archived on the company’s website for at least 30 days.